Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IMCDY | RYTM |
|---|---|---|
| Price | $53.45 | $92.45 |
| Change today | ▼ 0.65% | ▼ 0.41% |
| Market cap | $6.37B | $6.37B |
| Return, 3 months | +12.7% | -19.2% |
| Return, year to date | +20.3% | -13.6% |
| Return, 1 year | +0.7% | -5.5% |
| P/E (TTM) | 23.5 | -29.6 |
| P/B | 2.6 | 61.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.97% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 42 | 29 |
| 30-day volatility | 23.0% | 28.6% |
| Max drawdown, 1 year | -29.2% | -35.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.